University of New Mexico Cancer Center Support

位于一个丰富的多文化和多种族多样性，巨大的科学和技术能力， 挑战健康和社会经济差距，新墨西哥州癌症研究和治疗中心大学 (UNM CRTC）是唯一准备作出重大贡献的国家的使命，以减少癌症发病率 并消除死亡和癌症的痛苦。UNM CRTC的特点是多民族 癌症发病率和死亡率模式截然不同的人群， 区域科学和技术优势纳入其研究计划，以及广泛的网络和伙伴关系 这是它为参与性社区研究开发的。由NCI P20癌症中心规划补助金资助 自2000年9月1日以来，该中心取得了巨大的进步。在机构、国家和社区的大力支持下， CRTC已经雇佣了36名新的癌症专家和科学家;将其年度NCI翻了一番（直接成本为9，730，273美元+ 2，004，977美元的直接成本UNM NCI SEER计划）和同行评审的癌症资金总额（25，257，828美元）。 直接费用和35，517，100美元的总费用）;与Lovelace呼吸研究所正式达成联合体安排 研究所（LRRI）和桑迪亚国家实验室的合作伙伴关系;新诊断的患者人数增加了一倍 在CRTC接受治疗;显著增加患者参与临床试验（35%的患者累积至 干预研究，13%的治疗研究）;并保持了很高的照顾率，服务不足和少数民族 患者（在一个33%的癌症病例发生在少数民族的州，52%的患者在UNM接受治疗） CRTC是少数群体;所有类型的癌症方案的少数群体参与率为52%，治疗研究为38%。的 UNM CRTC的91名成员分为4个研究项目：癌症流行病学和预防， 癌症生物学，血液系统恶性肿瘤和女性癌症，专注于以下总体目标： 1.在我们的实验室，诊所和诊所进行杰出的多学科和跨学科癌症研究， 建立在独特的机构和区域科学优势和合作研究基础上的社区 与Lovelace呼吸研究所和新墨西哥州的国家实验室合作。 2.通过发现遗传、环境、社会和行为因素来降低癌症发病率和死亡率 导致了新墨西哥州多种族人群中不同的癌症模式。 3.通过以下措施减少西南部历史上服务不足人群的癌症健康差异： 与州卫生部、新墨西哥州普韦布洛人、部落和美国人合作的社区网络 印度国家;印度卫生服务;和当地社区通过发展文化上适当的癌症 教育、筛查和预防计划。 4.通过改善获得优质癌症护理的机会，为所有新墨西哥人提供出色的癌症治疗， 通过增加转诊和与社区癌症护理提供者的正式联系来创新疗法。 5.增加新墨西哥人获得和参与癌症临床研究和癌症治疗的机会 联合国特派团-社区联合临床试验协作网络（新 墨西哥癌症护理联盟）。

Located in a region of rich multicultural and multiethnic diversity, tremendous scientific and technological capability, and challenging health and socioeconomic disparity, The University of New Mexico Cancer Research and Treatment Center (UNM CRTC) is uniquely poised to make significant contributions to the Nation's mission to reduce cancer incidence and eliminate death and suffering from cancer. The special characteristics of the UNM CRTC are the multiethnic populations that it serves with their strikingly different patterns of cancer incidence and mortality, the integration of regional scientific and technologic strengths into its Research Programs, and the extensive networks and partnerships that it has developed for participatory community-based research. Funded by a NCI P20 Cancer Center Planning Grant since 9/1/2000, the Center has made tremendous progress. With significant institutional, State, and community support, the CRTC has hired 36 new cancer specialists and scientists; doubled its annual NCI ($9,730,273 in direct costs + $2,004,977 in direct costs to the UNM NCI SEER program) and total peer-reviewed cancer funding ($25,257,828 in direct and $35,517,100 in total costs); formalized consortium arrangements with the Lovelace Respiratory Research Institute (LRRI) and partnerships with Sandia National Laboratory; doubled the number of newly diagnosed patients treated at the CRTC; significantly increased patient participation in clinical trials (35% of all patients were accrued to intervention studies, 13% to therapeutic studies); and maintained very high rates of care to underserved and minority patients (in a State where 33% of cancer cases occur in ethnic minorities, 52% of the patients treated at the UNM CRTC were minorities; minority accrual to all types of cancer protocols was 52% and 38% to therapeutic studies). The 91 Members of the UNM CRTC are clustered into 4 Research Programs: Cancer Epidemiology and Prevention, Cancer Biology, Hematologic Malignancies, and Women's Cancers that are focused on the following overall goals: 1. To conduct outstanding multidisciplinary and trandisciplinary cancer research in our laboratories, clinics, and communities that builds on unique institutional and regional scientific strengths and collaborative research partnerships with the Lovelace Respiratory Research Institute and New Mexico's National Laboratories. 2. To reduce cancer incidence and mortality by discovering the genetic, environmental, social, and behavioral factors that contribute to the distinct cancer patterns in the multiethnic populations of New Mexico. 3. To reduce cancer health disparities in the historically underserved populations of the Southwest through collaborative community networks with the State Department of Health; New Mexico Pueblos, Tribes, and American Indian Nations; the Indian Health Service; and local communities by developing culturally appropriate cancer education, screening, and prevention programs. 4. To provide outstanding cancer treatment for all New Mexicans, by improving access to quality cancer care and innovative therapies through increased referrals and formal affiliations with community cancer care providers. 5. To increase access to and participation of New Mexicans in cancer clinical investigations and cancer therapeutic and prevention clinical trials, facilitated by a joint UNM-community collaborative clinical trials network (The New Mexico Cancer Care Alliance).